Is IRA becoming America’s HTA – ISPOR 2025
with Priti Jhingran, PhD and Tijana Ignjatovic, MA, PhD of Genesis Research Group
IRA Medicare drug price negotiation program introduces a negotiation mechanism for US drug pricing with HTA-like features. This raises the question of whether IRA is a de-facto HTA body – requiring clinical, economic, and RWE in a manner reminiscent of established HTA systems, and potentially shortening the profitable lifecycle for branded products.
Would you like to know more? Explore our website or get in touch via the form below.
